Femasys Inc. (FEMY)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
FEMY price, last 12 months
Key stats
- Previous close
- $2.43
- Open
- $2.43
- Day range
- $2.43 – $2.55
- 52-week range
- $2.02 – $22.20
- Volume
- 36.2K
- Avg volume (20 days)
- 98.1K
- Market cap
- $20.8M
Performance
Technicals and fundamentals
About Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $20.8M